Ngā hua rapu - Kaur, Kulvinder
- E whakaatu ana i te 1 - 15 hua o te 15
-
1
-
2
-
3
-
4
-
5
Clinical utilisation of a rapid low-pass whole genome sequencing technique for the diagnosis of aneuploidy in human embryos prior to implantation mā Wells, Dagan, Kaur, Kulvinder, Grifo, Jamie, Glassner, Michael, Taylor, Jenny C, Fragouli, Elpida, Munne, Santiago
I whakaputaina 2014Text -
6
A Screening Test for HLA-B(∗)15:02 in a Large United States Patient Cohort Identifies Broader Risk of Carbamazepine-Induced Adverse Events mā Fang, Hua, Xu, Xiequn, Kaur, Kulvinder, Dedek, Matthew, Zhu, Guang-dan, Riley, Bae J., Espin, Frank G., Del Tredici, Andria L., Moreno, Tanya A.
I whakaputaina 2019Text -
7
Hereditary mixed polyposis syndrome is caused by a 40kb upstream duplication that leads to increased and ectopic expression of the BMP antagonist GREM1 mā Jaeger, Emma, Leedham, Simon, Lewis, Annabelle, Segditsas, Stefania, Becker, Martin, Cuadrado, Pedro Rodenas, Davis, Hayley, Kaur, Kulvinder, Heinimann, Karl, Howarth, Kimberley, East, James, Taylor, Jenny, Thomas, Huw, Tomlinson, Ian
I whakaputaina 2012Text -
8
DNA polymerase ɛ and δ exonuclease domain mutations in endometrial cancer mā Church, David N., Briggs, Sarah E.W., Palles, Claire, Domingo, Enric, Kearsey, Stephen J., Grimes, Jonathon M., Gorman, Maggie, Martin, Lynn, Howarth, Kimberley M., Hodgson, Shirley V., Kaur, Kulvinder, Taylor, Jenny, Tomlinson, Ian P.M.
I whakaputaina 2013Text -
9
Targeted Next-Generation Sequencing of Plasma DNA from Cancer Patients: Factors Influencing Consistency with Tumour DNA and Prospective Investigation of Its Utility for Diagnosis mā Kaisaki, Pamela J., Cutts, Anthony, Popitsch, Niko, Camps, Carme, Pentony, Melissa M., Wilson, Gareth, Page, Suzanne, Kaur, Kulvinder, Vavoulis, Dimitris, Henderson, Shirley, Gupta, Avinash, Middleton, Mark R., Karydis, Ioannis, Talbot, Denis C., Schuh, Anna, Taylor, Jenny C.
I whakaputaina 2016Text -
10
Clinical applicability and cost of a 46-gene panel for genomic analysis of solid tumours: Retrospective validation and prospective audit in the UK National Health Service mā Hamblin, Angela, Wordsworth, Sarah, Fermont, Jilles M., Page, Suzanne, Kaur, Kulvinder, Camps, Carme, Kaisaki, Pamela, Gupta, Avinash, Talbot, Denis, Middleton, Mark, Henderson, Shirley, Cutts, Anthony, Vavoulis, Dimitrios V., Housby, Nick, Tomlinson, Ian, Taylor, Jenny C., Schuh, Anna
I whakaputaina 2017Text -
11
Dissecting the genetic complexity of human 6p deletion syndromes by using a region-specific, phenotype-driven mouse screen mā Bogani, Debora, Willoughby, Catherine, Davies, Jennifer, Kaur, Kulvinder, Mirza, Ghazala, Paudyal, Anju, Haines, Heather, McKeone, Richard, Cadman, Matthew, Pieles, Guido, Schneider, Jürgen E., Bhattacharya, Shoumo, Hardy, Andrea, Nolan, Patrick M., Tripodis, Nikos, Depew, Michael J., Chandrasekara, Ramya, Duncan, Gimara, Sharpe, Paul T., Greenfield, Andy, Denny, Paul, Brown, Steve D. M., Ragoussis, Jiannis, Arkell, Ruth M.
I whakaputaina 2005Text -
12
A candidate gene study of capecitabine-related toxicity in colorectal cancer identifies new toxicity variants at DPYD and a putative role for ENOSF1 rather than TYMS mā Rosmarin, Dan, Palles, Claire, Pagnamenta, Alistair, Kaur, Kulvinder, Pita, Guillermo, Martin, Miguel, Domingo, Enric, Jones, Angela, Howarth, Kimberley, Freeman-Mills, Luke, Johnstone, Elaine, Wang, Haitao, Love, Sharon, Scudder, Claire, Julier, Patrick, Fernández-Rozadilla, Ceres, Ruiz-Ponte, Clara, Carracedo, Angel, Castellvi-Bel, Sergi, Castells, Antoni, Gonzalez-Neira, Anna, Taylor, Jenny, Kerr, Rachel, Kerr, David, Tomlinson, Ian
I whakaputaina 2015Text -
13
VACTERL/caudal regression/Currarino syndrome-like malformations in mice with mutation in the proprotein convertase Pcsk5 mā Szumska, Dorota, Pieles, Guido, Essalmani, Rachid, Bilski, Michal, Mesnard, Daniel, Kaur, Kulvinder, Franklyn, Angela, El Omari, Kamel, Jefferis, Joanna, Bentham, Jamie, Taylor, Jennifer M., Schneider, Jurgen E., Arnold, Sebastian J., Johnson, Paul, Tymowska-Lalanne, Zuzanna, Stammers, Dave, Clarke, Kieran, Neubauer, Stefan, Morris, Andrew, Brown, Steve D., Shaw-Smith, Charles, Cama, Armando, Capra, Valeria, Ragoussis, Jiannis, Constam, Daniel, Seidah, Nabil G., Prat, Annik, Bhattacharya, Shoumo
I whakaputaina 2008Text -
14
Mutation burden and other molecular markers of prognosis in colorectal cancer treated with curative intent: results from the QUASAR 2 clinical trial and an Australian community-bas... mā Domingo, Enric, Camps, Carme, Kaisaki, Pamela J, Parsons, Marie J, Mouradov, Dmitri, Pentony, Melissa M, Makino, Seiko, Palmieri, Michelle, Ward, Robyn L, Hawkins, Nicholas J, Gibbs, Peter, Askautrud, Hanne, Oukrif, Dahmane, Wang, Haitao, Wood, Joe, Tomlinson, Evie, Bark, Yasmine, Kaur, Kulvinder, Johnstone, Elaine C, Palles, Claire, Church, David N, Novelli, Marco, Danielsen, Havard E, Sherlock, Jon, Kerr, David, Kerr, Rachel, Sieber, Oliver, Taylor, Jenny C, Tomlinson, Ian
I whakaputaina 2018Text -
15
Germline mutations in the proof-reading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas mā Palles, Claire, Cazier, Jean-Baptiste, Howarth, Kimberley M, Domingo, Enric, Jones, Angela M., Broderick, Peter, Kemp, Zoe, Spain, Sarah L, Almeida, Estrella Guarino, Salguero, Israel, Sherborne, Amy, Chubb, Daniel, Carvajal-Carmona, Luis G, Ma, Yusanne, Kaur, Kulvinder, Dobbins, Sara, Barclay, Ella, Gorman, Maggie, Martin, Lynn, Kovac, Michal B, Humphray, Sean, Lucassen, Anneke, Holmes, Christopher, Bentley, David, Donnelly, Peter, Taylor, Jenny, Petridis, Christos, Roylance, Rebecca, Sawyer, Elinor J, Kerr, David J., Clark, Susan, Grimes, Jonathan, Kearsey, Stephen E, Thomas, Huw JW, McVean, Gilean, Houlston, Richard S, Tomlinson, Ian
I whakaputaina 2012Text